These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6381432)

  • 41. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
    Hoshino T; Ito S; Asai A; Shibuya M; Prados MD; Dodson BA; Davis RL; Wilson CB
    Int J Cancer; 1992 Jan; 50(1):1-5. PubMed ID: 1728598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
    Phuphanich S; Levin EM; Levin VA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Continuous superselective intra-arterial infusion with BUdR and 5 FU in combination with radiotherapy in the treatment of head and neck tumors].
    Hattori T; Tashiro T; Toyota S; Hirano T; Nakagawa T; Yamaguchi N; Sakakura Y; Murata M
    Gan No Rinsho; 1988 Oct; 34(13):1893-902. PubMed ID: 3199521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Radiosensitization research in cancer therapy].
    Sugahara T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K; Hoshino T; Nagai M
    J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy.
    Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME
    Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors in vivo.
    Goffinet DR; Brown JM
    Radiology; 1977 Sep; 124(3):819-22. PubMed ID: 887782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraarterial iododeoxyuridine infusion combined with irradiation. A pilot study.
    Wirtanen GW; Wiley AL; Vermund H; Stephenson JA; Ansfield FJ
    Am J Clin Oncol; 1990 Aug; 13(4):320-3. PubMed ID: 2378311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical radiosensitization: why it does and does not work.
    Coleman CN; Mitchell JB
    J Clin Oncol; 1999 Jan; 17(1):1-3. PubMed ID: 10458210
    [No Abstract]   [Full Text] [Related]  

  • 53. Application of non-hypoxic cell sensitizers in radiobiology and radiotherapy: rationale and future prospects.
    Iliakis G; Kurtzman S
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1235-41. PubMed ID: 2654104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxic cell radiosensitizers in the treatment of malignant brain tumors.
    Gutin PH; Wara WM; Phillips TL; Wilson CB
    Neurosurgery; 1980 May; 6(5):567-76. PubMed ID: 6251398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
    Tanaka N; Takahashi M
    Nihon Rinsho; 1972 Dec; 30(12):2655-8. PubMed ID: 4675997
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy.
    Miller RW; DeGraff W; Kinsella TJ; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1193-7. PubMed ID: 3610707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
    Kiseleva ES; Dar'ialova SL
    Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719
    [No Abstract]   [Full Text] [Related]  

  • 58. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
    Mitchell JB; Kinsella TJ; Russo A; McPherson S; Rowland J; Smith BH; Kornblith PL; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):457-63. PubMed ID: 6303991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxic cell sensitizers for radiotherapy.
    Adams GE
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):135-41. PubMed ID: 632141
    [No Abstract]   [Full Text] [Related]  

  • 60. Intra-arterial 5-bromo-2-deoxyuridine (BUdR) radiosensitization with external beam radiation in rhesus monkeys: toxicity study.
    Greenberg HS; Chandler WF; Diaz RF; Averill DR; Gebarski SS; Lichter AS; Ensminger WD
    J Neurooncol; 1988 Dec; 6(4):349-54. PubMed ID: 3221261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.